Researchers at Kumamoto University have uncovered a previously unknown molecular mechanism by which human T-cell leukemia ...

Gyre Pharmaceuticals completed a Pre-NDA meeting with China’s CDE, which agreed that the existing Phase 3 clinical data support a conditional ...

The study shows that this drug pair works far better together than either agent alone, offering a realistic and potentially ...

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

Cellenkos® Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf, regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, announced that the U.S. Food ...

Rezdiffra FDA approval fuels sales; expansion to F4 MASH cirrhosis with 2027 trial data. Read more about MDGL stock here.

Age-related intervertebral disc (IVD) pathologies are a major driver of chronic low back pain and disability. Long framed as ...